Menu

The building housing the federal appeals court in Washington, D.C.

HHS, drugmakers and hospitals recently filed competing notices in a case on 340B rebates before a Washington, D.C., federal appeals court.

HHS, Drugmakers, Hospitals Clash Over Whether 340B Rebate Pilot Developments Impact Separate D.C. Circuit Case

February 20, 2026 William Newton, Associate Editor/Senior Writer 340B Report Views

The federal government, drugmakers and hospitals are debating whether the now-halted 340B rebate pilot—and the government’s recent moves to potentially [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

William Newton

Hawaii Federal Judge Lets Most Drugmaker Claims Against 340B Contract Pharmacy Access Law Proceed

Hospital, Pharmacist Groups Urge HRSA to Extend Comment Deadline on 340B Rebate RFI